Papetti, Michael External Entity

Publications

Sort by

Selected publications

  • Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach.  Investigational new drugs2014 Academic Article GET IT

Other